ParagGoyalMDMSc FACC FHFSA

Heart Failure & Transplantation

Director, Program for the Care and Study of the Aging Heart; Director, HFpEF and Cardiac Amyloidosis Program; Associate Professor of Medicine

Request Appointment

Overview of Dr. Goyal

Dr. Parag Goyal is a cardiologist in New York, NY and is affiliated with New York-Presbyterian Hospital. He received his medical degree from University of Massachusetts Medical School and has been in practice 7 years. He specializes in heart failure & transplantation, and cardiac critical care and is experienced in general cardiology, heart failure, cardiology, geriatric medicine, and critical care medicine.

Office
520 E 70th St
Fl 4
New York, NY 10021
Book by Phone+1(804) 495-3682

Fax+1 212-746-6665

Education & Training

Weill Cornell MedicineMSc, Clinical Epidemiology and Health Services Research, 2015 - 2017
New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 2013 - 2016
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2010 - 2013
University of Massachusetts Medical SchoolClass of 2010

Certifications & Licensure

NY State Medical License 2012 - 2026

Clinical Trials

Get Going: Accelerometer-Based Intervention to Promote Physical Activity in Frail Older Adults Start of enrollment: 2016 Jan 01
Unknown status
Not Applicable
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure Start of enrollment: 2016 Aug 01
Completed
Phase 4
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease Start of enrollment: 2017 Jul 11
Completed
Phase 2
TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure Start of enrollment: 2018 Jul 11
Completed
Phase 3
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure. Start of enrollment: 2018 Aug 27
Completed
Phase 3
CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) Start of enrollment: 2020 Mar 13
Active, not recruiting
Phase 3
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults Start of enrollment: 2020 Sep 01
Recruiting
Phase 4
N-of-1 for Beta-Blockers in Cardiac Amyloidosis Start of enrollment: 2024 Jan 31
Recruiting
Phase 4
Roles: Contact, Principal Investigator
A Preliminary Study for INFORMED Start of enrollment: 2024 Feb 07
Recruiting
Phase 4
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Emergency Department Use of Heart Failure-Exacerbating Medications in Patients with Chronic Heart Failure.
Martin F Casey, Joy Hallmark, Patricia P Chang, Jo E Rodgers, Aakash Mehta
Drug Safety. 2024-12-01
1 citations
Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: The REBALANCE-HF Randomized Clinical Trial.
Marat Fudim, Barry A Borlaug, Rajeev C Mohan, Matthew J Price, Peter Fail
JAMA Cardiology. 2024-12-01
Reductions in renin-angiotensin system inhibitors following hospitalization for heart failure.
Parag Goyal, Ligong Chen, Jennifer D Lau, Robert S Rosenson, Emily B Levitan
ESC Heart Failure. 2024-12-01

Journal Articles

Risk of Ischemic Stroke in Patients with Coronavirus Disease 2019 (COVID-19) vs Patients with Influenza
Alexander E Merkler, Neal S Parikh, Saad Mir, Hooman Kamel, Eaton Lin, Joshua Lantos, Edward J Schenck, Parag Goyal, Santosh B Murthy, Costantino Iadecola, Alan Z Sega..., JAMA Neurology
Use of Heart Failure Exacerbating Medications Among Adults with Heart Failure
Jerard Kneifati-Hayek, Monika M Safford, Parag Goyal, Journal of Cardiac Failure
Medication Counts for Adults with Heart Failure Do Not Differ According to Functional Impairment
Parag Goyal, MD, Journal of Cardiac Failure
Prevalence and Determinants of Hyperpolypharmacy in Adults with Heart Failure
Irina Sobol, Parag Goyal, Journal of Cardiac Failure
Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction: Insights on a Unique Clinical Phenotype from a Nationally-Representative United States Cohort
Parag Goyal, Zaid I Almarzooq, Jim Cheung, Udhay Krishnan, Dmitriy N Feldman, Evelyn M Horn, Luke K Kim, International Journal of Cardiology
Join now to see all

Lectures

Case 2 Troponin Elevation and ECG Changes in a Nursing Home Patient With Dementia
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Authored Content

Poll Results: Geriatric Conditions in Older Adults with Heart FailureSeptember 2020
Geriatric Update for the Cardiovascular Clinician: Prevalent Statin Use in Long-Stay Nursing Home Residents with Life-Limiting IllnessJuly 2020
Geriatric Update for the Cardiovascular Clinician: Prevalent Statin Use in Long-Stay Nursing Home Residents with Life-Limiting IllnessJuly 2020
Risk of Ischemic Stroke in Patients with Coronavirus Disease 2019 (COVID-19) vs Patients with InfluenzaJuly 2020
Risk of Ischemic Stroke in Patients with Coronavirus Disease 2019 (COVID-19) vs Patients with InfluenzaJuly 2020
Use of Heart Failure Exacerbating Medications Among Adults with Heart FailureNovember 2018
Medication Counts for Adults with Heart Failure Do Not Differ According to Functional ImpairmentAugust 2018
Join now to see all

Press Mentions

Palliative Care Beneficial to Manage Symptoms, Improve Quality of Life for People with CVDJuly 1st, 2024
A-fib After Any Surgery Raises Odds for Heart FailureJuly 7th, 2022
Stroke-Inducing Heart Conditions Have Increased up to 72 Per Cent in EnglandJuly 6th, 2022
Join now to see all

Grant Support

A Novel Deprescribing Intervention for Heart Failure with Preserved Ejection Fraction (HFpEF): A Prototype for Older Adults with Multimorbidity and PolypharmacyNational Institute on Aging2020–2025
Successful Aging and Cardiovascular DiseaseAmerican Heart Association2020–2023
Impact of Beta-blocker on Physical Function in Heart Failure with Preserved Ejection Fraction (HFpEF)New York Academy of Medicine2019–2021
Safety of Neurohormonal Antagonist Initiation Among Older Adults Following a Heart Failure HospitalizationAmerican Heart Association2018–2021
Heart Failure Preserved Ejection Fraction Program for the AgingFan Fox & Leslie R. Samuels Foundation2018–2020
Impact of Polypharmacy on Rehospitalization in Older Adults with Heart FailureNational Institute on Aging2017–2019
Glorney-Raisbeck Fellowship AwardNew York Academy of Medicine2016–2017

Committees

Chair, REGARDS Heart Failure Working Group 2018 - Present
Chair, American College of Cardiology Geriatric Cardiology Section FIT/ECP Working Group 2018 - Present
Member, American College of Cardiology Geriatric Cardiology Section Leadership Council 2015 - Present